Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | SLC26A6 | Q9BXS9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1438204 | 0.90 | SMN1; SMN2 (0.42) | SMN1; SMN2HTTALDH1A1GABRA2GABRB2 | |
| SCHEMBL1440045 | 0.86 | GABRA2 (0.47) | SMN1; SMN2HTTALDH1A1GABRA2GABRB2 | |
| SCHEMBL10002384 | 0.84 | MAPT (0.41) | SMN1; SMN2HTTALDH1A1MAPTMEN1 | |
| SCHEMBL1437481 | 0.80 | RXFP1 (0.42) | SMN1; SMN2HTTALDH1A1GABRA2GABRB2 | |
| SCHEMBL5349522 | 0.80 | CNR1 (0.39) | SMN1; SMN2HTTALDH1A1MAPTLMNA | |
| SCHEMBL9893887 | 0.78 | CYP1A2 (0.46) | SMN1; SMN2HTTALDH1A1GABRA2GABRB2 | |
| SCHEMBL5359284 | 0.78 | CNR1 (0.42) | SMN1; SMN2MAPTPOLB | |
| SCHEMBL1437578 | 0.77 | SMN1; SMN2 (0.45) | SMN1; SMN2HTTALDH1A1GABRA2GABRB2 | |
| SCHEMBL9893919 | 0.77 | SMN1; SMN2 (0.43) | SMN1; SMN2HTTALDH1A1GABRA2GABRB2 | |
| SCHEMBL23027868 | 0.75 | GABRA2 (0.41) | SMN1; SMN2ALDH1A1GABRA2GABRB2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120149661-A1 | TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS | NOVARTIS AG (CH) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149661-A1 | TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS | MDM4, MDM2, TP53 | SMN1; SMN2 886/4885HTT 82/4885ALDH1A1 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.